GlassScriptPhysician profile
Jamie T Choi
NPI 1952843286
$192.35
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $49.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.73 | 2021 | |
| Bioventus LLC | $20.52 | 2021 | |
| Nalu Medical, INC. | $20.31 | 2021 | |
| Grt US Holding, INC. | $19.88 | 2021 | |
| Nevro Corp. | $17.45 | 2021 | |
| Abbott Laboratories | $17.27 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.25 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.